Document is current
Any future updates will be listed below
-
Authors
Thomassin-Naggara, Isabelle https://orcid.org/0000-0002-0919-0133
Dolciami, Miriam
Chamie, Luciana P.
Guerra, Adalgisa
Bharwani, Nishat
Freeman, Sue
Rousset, Pascal
Manganaro, Lucia
,
Guerra, Adalgisa
Avesani, Giacomo
Bazot, Marc
Cunha, Teresa Margarida
Franco, Paolo Niccolò
Forstner, Rosemarie
Gui, Benedetta
Kermarrec, Edith
Rizzo, Stefania
Sahin, Hilal
Mansournia, Shiwa
Thomassin-Naggara, Isabelle
Villalba, Laura Buñesch
Woitek, Ramona
- License Information
-
More Information
Article History
Received: 14 October 2024
Revised: 10 March 2025
Accepted: 24 March 2025
First Online: 27 May 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Isabelle Thomassin-Naggara.
: I.T.-N. declares the following disclosures: speakers bureaus: European Society of Breast Imaging (active), Société d’imagerie de la femme (active), American College of Radiology O-RADS (active), Bayer (ended), Siemens Healthineers (ended), Guerbet (ended), and Bard (ended). Punctual remunerated lectures: GE, Siemens, Guerbet, Hologic, Canon, Guebet, Bracco, GSD, Samsung, Fujifilm, Incepto, and ICADe. Research grants—ASCORDIA: ADNEX MR Scoring System: impact of an MR scoring system on therapeutic strategy of pelvic adnexal masses, PHRC ID RCB 2015-A01593-46. P.R. declares the following disclosures: consultancies with ZIWIG and EDAP TMS France. L.P.C. declares the following disclosures: punctual remunerated lectures for the Cleveland Clinic Imaging Institute. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was not required.
: Some study subjects or cohorts have been previously reported in XXX.
:
